6505--Radioactive (Xofigo) Isotopes Notice of Intent to Sole Source
ID: 36C25624Q0041Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF256-NETWORK CONTRACT OFFICE 16 (36C256)RIDGELAND, MS, 39157, USA

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/2cae128c7040471ca5be1bd196e4fd72/view
Timeline
  1. 1
    Posted Oct 5, 2023 4:11 PM
  2. 2
    Updated Oct 5, 2023 4:11 PM
  3. 3
    Due Oct 9, 2023 10:00 PM
Description

Special Notice: VETERANS AFFAIRS, DEPARTMENT OF intends to negotiate a sole source Firm-Fixed Price contract for the procurement of Radioactive (Xofigo) Isotopes- RADIUM RA 223 DICHLORIDE INJECTION for the Michael E. DeBakey VA Medical Center located in Houston, Texas with Cardinal Health, Inc. This service is typically used for medical purposes at the VA Medical Center.

Point(s) of Contact
Jeneice MatthewsContract Specialist
713-791-1414 ext. 44002
jeneice.matthews@va.gov
Files
Title
Posted
36C25624Q0041.docx
3/26/2024
36C25624Q0041 Special Notice.pdf
3/26/2024
Lifecycle
Title
Type
6505--Radioactive (Xofigo) Isotopes Notice of Intent to Sole Source
Currently viewing
Special Notice
Similar Opportunities
3650--Radiopharmaceutical (VA-24-00070426)
Active
Veterans Affairs, Department Of
The Department of Veterans Affairs (VA) seeks radiopharmaceuticals for the Syracuse VA Medical Center in New York. The combined synopsis and solicitation document outlines a requirement for a firm fixed-price contract to supply these pharmaceuticals, with a focus on meeting the center's needs. The scope of work involves the provision of radiopharmaceuticals and associated services, with the potential for renewal options. The VA emphasizes the need for timely delivery and the ability to fulfill sudden increases in demand. Eligible applicants should have a strong track record in pharmaceutical manufacturing, with the NAICS code 325412 and a corresponding size standard of 1,300 employees. To demonstrate their ability to meet the VA's requirements, bidders must submit comprehensive quotes outlining their capabilities. Funding for this unrestricted opportunity is estimated at $600,000 to $700,000. The contract type is a firm fixed price contract, and the submission deadline is available in SAM.gov. The VA will evaluate bids based on their compliance with the requirements, considering past performance, price, and delivery timelines. Interested parties should direct any inquiries to Morgan Weeks at Morgan.Weeks1@va.gov or via phone at (607) 664-4708. This summary provides an overview of the VA's radiopharmaceutical contract opportunity, combining information from the government listing and associated files. For more details, prospective bidders are advised to refer to the full solicitation document and SAM.gov.
6505--Plyarify - Radiopharmaceuticals
Active
Veterans Affairs, Department Of
Special Notice: VETERANS AFFAIRS, DEPARTMENT OF is seeking to procure Plyarify - Radiopharmaceuticals. Plyarify is a radioactive diagnostic agent used for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer. The procurement involves the preparation and delivery of F-18 Piflufolastat (Pylarify) doses performed at a contractor facility and delivered to the PET/CT Service at VA Connecticut Healthcare in West Haven, CT. Deliveries will be made Monday through Friday between 7:00 am and 3:00 pm. Only vendors within a 60-mile radius of VA Connecticut need to respond to this RFQ. The contractor's personnel must be licensed in a State, Territory, or Commonwealth of the United States or the District of Columbia. The contractor will bill on a monthly basis, itemizing all services rendered. The services covered by this contract shall be furnished by the contractor Monday through Friday, 7:00 am - 3:00 pm. There is no restriction on the number of orders or deliveries required per day. The delivery location is VA Connecticut Healthcare System in West Haven, CT. Interested parties must submit their capability to fulfill the requirement in writing by Monday, July 15, 2024, at 12 pm EST time.
6505--Neuraceq - Radiopharmaceuticals
Active
Veterans Affairs, Department Of
Special Notice: VETERANS AFFAIRS, DEPARTMENT OF is seeking a sole source procurement for Neuraceq - Radiopharmaceuticals. Neuraceq is a radioactive diagnostic agent used for Positron Emission Tomography (PET) imaging of the brain. It is used to estimate -amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer's Disease (AD) and other causes of cognitive decline. The procurement involves the preparation and delivery of F-18 Florbetaben (NeuraCeq) doses performed at a contractor facility and delivered to the PET/CT Service at VA Connecticut Healthcare in West Haven, CT. The deliveries will be made Monday through Friday between 7:00 am and 3:00 pm. Only vendors within a 60-mile radius of VA Connecticut need to respond to this RFQ.
Solicitation-Radiopharmaceuticals -Evans Army Community Hospital
Active
Dept Of Defense
The Evans Army Community Hospital in Fort Carson, Colorado, is seeking radiopharmaceuticals through a federal contract. The main purpose of this solicitation, W81K00-24-Q-0167, is to obtain these specialized pharmaceuticals for the hospital's needs. ## Scope of Work The successful awardee will be responsible for supplying radiopharmaceuticals as outlined in the attached Statement of Work (SOW). The SOW details the specific requirements and expectations, including the delivery of a comprehensive range of radiopharmaceuticals. Awardees will need to provide pricing information for the products listed in the attached RPH Product List. ## Eligibility Criteria Eligible applicants for this opportunity should have expertise and experience in the pharmaceutical industry, specifically in manufacturing and supplying radiopharmaceuticals. The ability to comply with the specific requirements outlined in the SOW and meet the pricing expectations is crucial. ## Funding and Contract Details The contract type is not specified in the provided information. However, the notice emphasizes the importance of reviewing the relevant FAR (Federal Acquisition Regulation) addenda for instructions and evaluation criteria. The estimated funding for this contract is not available in the provided information. ## Submission Process Offerors are required to submit their questions by email, with a copy to both the primary and secondary contact, by the deadline of 10:00 AM (Mountain) on July 31, 2024. The submissions should refer to the attached documents, specifically the SOW and RPH Product List, when crafting their proposals. ## Evaluation Criteria The evaluation of offers will be based on the guidelines outlined in the FAR 52.212-1 and FAR 52.212-2 addenda. The specific evaluation criteria are not provided in the information supplied, but typically include factors such as price, technical merit, and past performance. ## Contact Information For any questions or clarifications, offerors should contact the primary contact, Fabiola Palma-Trujillo, via email at fabiola.palma-trujillo.civ@health.mil. Ms. Robyn Villafranco should also be copied on all communications (email: Robyn.A.Villafranco.civ@health.mil). Please note that the above summary is based on the information provided and may not cover all the nuances of the opportunity. For a comprehensive understanding, carefully review the attached documents referenced in the opportunity listing.
6505--PET MRI Radiopharmaceuticals - Detroit VAMC
Active
Veterans Affairs, Department Of
The Department of Veterans Affairs is seeking experienced contractors for a potential five-year IDIQ contract to supply PET MRI Radiopharmaceuticals to the John D. Dingell VA Medical Center in Detroit, Michigan. The goal is to ensure a steady supply of these specialized pharmaceuticals to enhance the center's medical capabilities. ## Opportunity Overview This sources sought notice is issued for market research purposes to gauge interest and capability in meeting the VA Medical Center's requirements. The center requires a reliable supply of a range of PET radiopharmaceuticals, including Cu64 Dotatate, F18 PSMA, F18 FDG, and F18 Vizamyl, for medical purposes. ## Scope of Work The selected contractor will be responsible for fulfilling orders of these pharmaceuticals, ensuring timely deliveries, and adhering to strict quality control measures. They must employ registered radio-pharmacists and provide a trouble-shooter to assist with any issues. Additionally, the contractor must manage waste products disposal and comply with regulations regarding shipping and handling. ## Schedule of Supplies - Cu64 Dotatate: 3-5 mCi Each, 10 doses annually - F18 PSMA: 8-10 mCi Each, 52 doses annually - F18 FDG: 8-10 mCi Each, 780 doses annually - F18 Vizamyl/F18 Neuraceq/F18 Amyvid: 8-10 mCi Each, 52 doses annually ## Eligibility Criteria This opportunity is open to businesses capable of meeting the stringent requirements for handling and supplying these specialized pharmaceuticals. Registration in the System for Award Management (SAM) is mandatory. Contractors claiming small business preferences must meet relevant FAR guidelines and register with the SBA. ## Funding and Contract Details Funding for this contract is estimated at approximately $1.5 million over the five-year period. The contract type is an IDIQ contract with a potential ordering period from October 1, 2024, to September 30, 2029. ## Submission Process Interested parties should provide a response to the Contracting Officer, Jeffrey Rozema, via email by the deadline. The email should include: - Business Name and Address - Point of Contact Details - SAM Unique Entity ID - Type of Small Business, if applicable - A detailed description of the company's ability to meet the requirements, including facility locations and relevant experience. ## Evaluation Criteria Responses will be evaluated based on the extent to which they demonstrate an ability to meet the stated requirements. The VA will select vendors capable of providing a reliable supply of the required pharmaceuticals under the specified conditions. ## Contact Information For clarification or further information, interested parties can contact Jeffrey Rozema, Contracting Officer, via email at jeffrey.rozema@va.gov or by phone at 269-966-5600 ext. 36450. The government encourages interested parties to respond, as this is a sources sought notice to gauge interest and capability.